Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

$24.99

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check

Bristol-Myers Squibb Co., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net earnings (loss)
Depreciation and amortization, net
Deferred income taxes
Stock-based compensation
Impairment charges
Divestiture gains and royalties
Acquired IPRD
Equity investment (gains) losses, net
Contingent consideration fair value adjustments
Other adjustments
Receivables
Inventories
Accounts payable
Rebates and discounts
Income taxes payable
Other
Changes in operating assets and liabilities
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
Net cash provided by operating activities
Sale and maturities of marketable debt securities
Purchase of marketable debt securities
Proceeds from sales of equity investments
Capital expenditures
Divestiture and other proceeds
Acquisition and other payments, net of cash acquired
Net cash (used in) provided by investing activities
Proceeds from issuance of short-term debt obligations
Repayments of short-term debt obligations
Other short-term financing obligations, net
Proceeds from issuance of long-term debt
Repayments of long-term debt
Repurchase of common stock
Dividends
Stock option proceeds and other, net
Net cash provided by (used in) financing activities
Effect of exchange rates on cash, cash equivalents and restricted cash
Increase (decrease) in cash, cash equivalents and restricted cash

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The cash flow profile is characterized by stable operational cash generation punctuated by a significant strategic acquisition event in the first quarter of 2024. While net earnings exhibited extreme volatility during this period, the ability to generate cash from core operations remained resilient, providing a consistent foundation for capital expenditures and shareholder returns.

Operating Cash Flow and Earnings Reconciliation
Net cash provided by operating activities generally fluctuated between $1.8 billion and $6.3 billion per quarter. A critical divergence occurred in March 2024, where a reported net loss of $11.9 billion was fully offset by non-cash adjustments totaling $14.7 billion. This reconciliation was primarily driven by $12.9 billion in acquired in-process research and development (IPRD), indicating that the earnings loss was largely a result of accounting charges related to an acquisition rather than an operational failure.
Investing Activities and Strategic Growth
Investing activities were dominated by a massive outflow of $19.6 billion in March 2024, directly linked to $20.1 billion in acquisition and other payments. Outside of this event, capital expenditures remained remarkably consistent, typically ranging between $250 million and $380 million per quarter. The company also maintained active liquidity management through the periodic sale and purchase of marketable debt securities.
Financing Activities and Capital Structure
Financing activities reflect a strategy of utilizing debt to fund major growth while maintaining steady shareholder distributions. The acquisition in early 2024 was heavily financed through the issuance of $12.9 billion in long-term debt. Debt repayment patterns were intermittent but significant, notably a $10.1 billion repayment in December 2025. Stock repurchases were aggressive between 2021 and 2023 but decreased substantially in subsequent periods.
Shareholder Return Consistency
Dividend payments demonstrate a high degree of stability and a gradual upward trend, increasing from approximately $1.1 billion per quarter in 2021 to nearly $1.3 billion by mid-2026. This consistency suggests a prioritized commitment to dividend distributions regardless of quarterly earnings volatility or large-scale investing activities.
Working Capital Dynamics
Changes in operating assets and liabilities showed significant quarterly swings, particularly in rebates and discounts and income taxes payable. These fluctuations often offset or augmented the cash flow from operations, but they did not disrupt the overall positive trend of net cash provided by operating activities.